COSCIENS Biopharma Inc. Increase Decrease Through Acquisition Of Subsidiary
COSCIENS Biopharma Inc. (CSCIF) reported Increase Decrease Through Acquisition Of Subsidiary of $8.49 million for the 12-month period ending 2024-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary · last filed 2026-03-25
- COSCIENS Biopharma Inc. increase decrease through acquisition of subsidiary for the quarter ending 2024-12-31 was $0.00.
- COSCIENS Biopharma Inc. increase decrease through acquisition of subsidiary for the quarter ending 2024-09-30 was $0.00.
| Period end | Increase Decrease Through Acquisition Of Subsidiary 3 month | Increase Decrease Through Acquisition Of Subsidiary 6 month | Increase Decrease Through Acquisition Of Subsidiary 9 month | Increase Decrease Through Acquisition Of Subsidiary 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $8.49M 20-F · filed 2026-03-25 | |
| 2024-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $8.49M 6-K · filed 2025-11-12 | ||
| 2024-06-30 | $8.49M 6-K · filed 2025-08-14 |